ESR1 and breast carcinoma: First, FOXA1 is a critical determinant of estrogen receptor signaling and is required for cell cycle progression and proliferation of luminal breast cancer, which accounts for the majority of breast cancer diagnoses [38,43,44,45,46,47,61].